Does the Macrophage Migration Inhibitory Factor in Ascites in patients with ovarian carcinoma effects the prognosis of ovarian carcinoma?

被引：0
|
作者：
Krockenberger, M. [1 ]
Haeusler, S. [1 ]
Engel, J. B. [1 ]
Dietl, J. [1 ]
Hoenig, A. [1 ]
机构：
[1] Univ Frauenklin Wurzburg, Wurzburg, Germany
来源：
GEBURTSHILFE UND FRAUENHEILKUNDE | 2009年 / 69卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：750 / 750
页数：1
相关论文
共 50 条
  • [41] OVARIAN CARCINOMA - PATHOLOGY, STAGING, GRADING, AND PROGNOSIS
    SOMMERS, SC
    LONG, ME
    BULLETIN OF THE NEW YORK ACADEMY OF MEDICINE, 1973, 49 (10) : 858 - 869
  • [42] Positive Ascites Cytology, Postoperative Chemotherapy and Prognosis of Stage I Ovarian Clear Cell Carcinoma
    Kubo-Kaneda, Michiko
    Kondo, Eiji
    Okugawa, Toshiharu
    Yamawaki, Takaharu
    Hirata, Toru
    Tsuji, Makoto
    Nagao, Kenji
    Kato, Maya
    Yoshimura, Koichi
    Ikeda, Tomoaki
    ANTICANCER RESEARCH, 2023, 43 (08) : 3799 - 3805
  • [43] OVARIAN CARCINOMA - PHYSICIANS OBLIGATION TO IMPROVE PROGNOSIS
    LEWIS, GC
    POSTGRADUATE MEDICINE, 1961, 30 (05) : 433 - +
  • [44] EFFECTS OF INTERFERON-ALPHA ON MACROPHAGE ACTIVATION IN PATIENTS WITH OVARIAN-CARCINOMA AND CERVICAL DYSPLASIA
    FUITH, LC
    FUCHS, D
    HAUSEN, A
    HETZEL, H
    REIBNEGGER, G
    WERNER, ER
    WACHTER, H
    JOURNAL OF CLINICAL & LABORATORY IMMUNOLOGY, 1989, 29 (02) : 65 - 69
  • [45] Macrophage Capping Protein CapG Is a Putative Oncogene Involved in Migration and Invasiveness in Ovarian Carcinoma
    Glaser, J.
    Neumann, M. H. D.
    Mei, Qi
    Betz, B.
    Seier, N.
    Beyer, I.
    Fehm, T.
    Neubauer, H.
    Niederacher, D.
    Fleisch, M. C.
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [46] Expression and therapeutic potential of macrophage migration inhibitory factor and CD74 in ovarian cancer
    Lee, Y. S.
    Baek, J. M.
    Park, E. K.
    Kim, C. J.
    Lee, H. J.
    Kim, J. O.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2020, 41 (01) : 65 - 69
  • [47] Expression of leukaemia inhibitory factor in epithelial ovarian carcinoma: correlation with clinical characteristics
    Ye, F.
    Hu, Y.
    Lu, W.
    Zhou, C.
    Xie, X.
    HISTOPATHOLOGY, 2008, 53 (02) : 224 - 228
  • [48] Comparison of CEA and CA 125 levels in the ascites and serum of patients with ovarian carcinoma
    Yalçin, S
    Güllü, I
    CANCER INVESTIGATION, 1998, 16 (06) : 426 - 427
  • [49] Glucose as a prognostic factor in ovarian carcinoma
    Lamkin, Donald M.
    Spitz, Douglas R.
    Zimmerman, Bridget
    DeGeest, Koen
    Lubaroff, David M.
    Sood, Anil K.
    Lutgendorf, Susan K.
    ANNALS OF BEHAVIORAL MEDICINE, 2008, 35 : S125 - S125
  • [50] Glucose as a Prognostic Factor in Ovarian Carcinoma
    Lamkin, Donald M.
    Spitz, Douglas R.
    Shahzad, Mian M. K.
    Zimmerman, Bridget
    Lenihan, Daniel J.
    DeGeest, Koen
    Lubaroff, David M.
    Shinn, Eileen H.
    Sood, Anil K.
    Lutgendorf, Susan K.
    CANCER, 2009, 115 (05) : 1021 - 1027
12345